Get the facts on diseases, conditions, tests and procedures.
Enter the last name, specialty or keyword for your search below.
Female
Expertise: Cardiology, Cardiology Consultation, Cardiovascular Disease, Cardiovascular Disease in Women, Cardiovascular Diseases, Coronary Artery Disease, Echocardiography, Heart Disease, Heart Disease Prevention and Treatment in Women, High Cholesterol, Hypertension, Lipid Disorders, Preventive Cardiology, Stress Testing, Transesophogeal Echocardiography (TEE), Vitamin D Deficiency ...read more
Research Interests: Women and heart disease; vitamin D and cardiovascular health; preventive cardiology; subclinical atherosclerosis imaging; sex hormones and cardiovascular disease ...read more
443-997-0270
Request an appointment through My
410-464-6641
Request Appointment
+1-410-502-7683
Request Appointment
1800 Orleans St.
Sheikh Zayed Tower
Baltimore, MD 21287
map
1132 Annapolis Road
Odenton, MD 21113
map
Phone: 410-874-1520
Fax: 410-502-0231
Dr. Erin D. Michos is an Associate Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Associate Director of Preventive Cardiology with the Ciccarone Center for the Prevention of Cardiovascular Disease at Johns Hopkins. She is a Fellow of the American College of Cardiology (FACC) and a Fellow of the American Heart Association (FAHA).
Dr. Michos completed medical school at Northwestern University in Chicago, IL, and then completed both her Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital in Baltimore, MD. She also completed her Masters of Health Science degree in Cardiovascular Epidemiology at the Johns Hopkins Bloomberg School of Public Health.
Her research interests are in the areas of Preventive Cardiology and Cardiovascular Epidemiology, with particular focus on (1) physical activity and nutrition; (2) risk prediction for cardiovascular disease including the use of coronary artery calcium scores and biomarkers, (3) lipids and statin therapy, (4) cardiovascular disease among women, and (4) vitamin D.
As part of the Johns Hopkins cardiology faculty, her clinical duties entail seeing patients in the Preventive Cardiology outpatient clinic and the Echocardiography lab. She also teaches students at the Johns Hopkins University Medical School and the Bloomberg School of Public Health. She is the Chair of the Women’s Task Force for the Cardiology Division at Johns Hopkins. She is part of the Editorial Board for the journal Circulation.
Dr. Michos is the recipient of independent investigator funding through the National Institutes of Health (NIH) RO1 mechanism. She is a co-investigator in the NIH-funded Multi-Ethnic Study of Atherosclerosis (MESA) and Atherosclerosis Risk in Communities (ARIC) studies. She is an investigator in an on-going NIH-funded clinical trial studying vitamin D and fall prevention called the STURDY trial. She is the Training Director for the AHA fellowship program for the AHA’s Go Red for Women Strategic Focus Research Network at Johns Hopkins for research in women’s cardiovascular health.
Dr. Michos has authored or co-authored over 200 manuscripts in peer reviewed journals. She also contributes a monthly article for the US News and World Report Health Section for the public audience. She is also a frequent contributing writer to Johns Hopkins Medicine’s Healthy Heart and Healthy Woman websites.
Select Publications related to cholesterol, lipids:
1. Michos ED. Blumenthal RS. The Prevalence of Low LDL-Cholesterol with Elevated High Sensitivity C-reactive Protein in the United States: Implications of the JUPITER Study. J Am Coll Cardiol 2009; 53: 931-935, PMID: 19281922.
2. . Blumenthal RS, Michos ED. The HALTS trial – halting atherosclerosis or halted too early? N Engl J Med. 2009 Nov 26;361(22):2178-80. Epub 2009 Nov 15, PMID:19915216.
3. Michos ED, Sibley CT, Baer JT, Blaha MJ, Blumenthal RS. Niacin and Statin Combination Therapy for Atherosclerosis Regression and Prevention of Cardiovascular Disease Events: Reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Trial With Previous Surrogate Endpoint Trials. J Am Coll Cardiol. 2012 Jun 5;59(23):2058-64, PMID: 22520249
4. Blaha MJ, Michos ED. Niacin--a case study for the role of event-driven versus surrogate endpoint trials. Heart. 2013;99(22):1631-2.
5. Long SB, Blaha MJ, Blumenthal RS, Michos ED. Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly. Clinical Interventions in Aging. 2011; 6:27-35.
6. Martin SS, Michos ED. Are we moving towards concordance on the principle that lipid discordance matters? Circulation. 2014;129(5):539-41.
7. Martin SS, Michos ED. Mapping hyperlipidemia in young adulthood to coronary risk: importance of cumulative exposure and how to stay young. Circulation. 2015;131(5):445-7.
8. Subedi BS, Joshi PH, Jones SR, Martin SS, Blaha MJ, Michos ED. Current Guidelines for HDL in Therapy and Future Directions. Vascular Health and Risk Management. 2014;10:1-12.
Select publications related to vitamin D
1. Melamed ML*, Michos ED*, Post W, Astor B. 25(OH) Vitamin D Levels and the Risk of Mortality in the General Population. Archives of Internal Medicine 2008:168;1629-37. *These authors contributed equally to the work. PMID:18695076, PMCID: PMC2677029
2. Michos ED, Streeten EA, Ryan KA, Rampersaud E, Peyser PA, Bielak LF, Shuldiner AR, Mitchell BD, Post W. Serum 25-hydroxyvitamin D levels are not associated with subclinical vascular disease or C-reactive protein in the Old Order Amish. Calcific Tissue International 2009 Mar;84(3):195-202, PMID:19148561.
3. Michos ED, Reis JP, Post WS, Lutsey PL, Gottesman RF, Mosley TH, Sharret AR, Melamed ML. 25(OH)D deficiency is associated with fatal stroke among whites but not blacks: The NHANES-III linked mortality files. Nutrition 2012 Apr;28(4):367-71. PMID:22261577 ; PMCID: PMC3304002
4. Michos ED, Carson KA, Schneider ALC, Lutsey PL, Xing L, Sharrett AR, Alonso A. Coker LH, Gross M, Post W, Mosley TH, Gottesman RF. Vitamin D and Subclinical Cerebrovascular Disease: The Atherosclerosis Risk in Communities Brain Magnetic Resonance Imaging Study. JAMA Neurol. 2014; 71(7):863-71.PMID: 24861877; PMCID: PMC4218739.
5. Schneider ALC, Lutsey PL, Alonso A, Gottesman RF, Sharrett AR, Carson KA, Gross M, Post WS, Knopman DS, Mosley TH, Michos ED. Vitamin D and Cognitive Function and Dementia Risk in a Biracial Cohort: the ARIC Brain Ancillary Study. Eur J Neurol. 2014;21(9):1211-8, e69-70. PMID: 24846449 PMCID: PMC4114998.
Select publications related to cardiovascular disease in women:
1. Michos ED, Nasir K, Braunstein JB, Rumberger JA, Budoff MJ, Post WS, Blumenthal RS. Framingham Risk Equation Underestimates Subclinical Atherosclerosis Risk in Asymptomatic Women. Atherosclerosis 2006; 184:201-6. PMID:15907856
2. Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, Dolor RJ, Ganiats TG, Gomes AS, Gornik HL, Gracia C, Gulati M, Haan CK, Judelson DR, Keenan N, Kelepouris E, Michos ED, Newby LK, Oparil S, Ouyang P, Oz M, Petitti D, Pinn VW, Redberg R, Scott R, Sherif K, Smith S, Spoko G, Steinhorn RH, Stone NJ, Taubert K, Todd BA, Urbina E, Wenger NK. American Heart Association Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women: 2007 Update. Expert Panel/Writing Group. Circulation;115(11):1481-501, PMID:17309915.
3. Michos ED, Blumenthal RS. How accurate are 3 risk prediction models in US women? Circulation 2012,;125(14):1723-6. PMID: 22399534
Select publications related to other risk markers and risk assessment:
1. Michos ED, Wilson LM, Yeh HC, Berger Z, Suarez-Cuervo C, Stacy SR, Bass EB. Prognostic Value of Cardiac Troponin in Patients With Chronic Kidney Disease Without Suspected Acute Coronary Syndrome: A Systematic Review and Meta-analysis. Ann Intern Med. 2014;161(7):491-501. PMID:25111499
2. Whelton SP, Narla V, Blaha MJ, Nasir K, Blumenthal RS, Jenny NS, Al-Mallah MH, Michos ED. Association between resting heart rate and inflammatory biomarkers (high-sensitivity C-reactive protein, interleukin-6, and fibrinogen) (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol. 2014; 113(4):644-9. PubMed PMID: 24393259; PubMed Central PMCID: PMC4280910.
3. Amin NP, Martin SS, Blaha MJ, Nasir K, Blumenthal RS, Michos ED. Headed in the Right Direction but at Risk for Miscalculation: A Critical Appraisal of the 2013 ACC/AHA Risk Assessment Guidelines. J Am Coll Cardiol. 2014;63(25 Pt A):2789-94. PMID:24814487; PMCID: PMC4280905.
4. Aladin AI, Whelton SP, Al-Mallah MH, Blaha MJ, Keteyian SJ, Juraschek SP, Rubin J, Brawner CA, Michos ED. Relation of resting heart rate to risk for all-cause mortality by gender after considering exercise capacity (the Henry Ford exercise testing project).Am J Cardiol. 2014 Dec 1;114(11):1701-6. PubMed PMID: 25439450.
600 N. Wolfe Street
Blalock 524-B
Baltimore, MD 21287
map
Phone: 410-502-6813
Language Assistance Available:
© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
Comments